A novel mouse model of coronary stenosis mimicking Kawasaki disease induced by Lactobacillus casei cell wall extract.
Kawasaki disease
coronary stenosis
elastin degradation
intimal proliferation
vascular smooth muscle cell
Journal
Experimental animals
ISSN: 1881-7122
Titre abrégé: Exp Anim
Pays: Japan
ID NLM: 9604830
Informations de publication
Date de publication:
24 Apr 2020
24 Apr 2020
Historique:
pubmed:
15
1
2020
medline:
5
8
2020
entrez:
15
1
2020
Statut:
ppublish
Résumé
Kawasaki disease (KD), a febrile systemic vasculitis in infants associated with coronary aneurysm, is a major cause of cardiac sequelae such as myocardial infarction (MI) and sudden death. These events are caused by coronary stenosis due to intimal proliferation or thrombotic formation; however, histological evaluation is limited to autopsy cases of human KD. We therefore investigated the histological features of coronary artery (CA) stenosis in mice induced by Lactobacillus casei cell wall extract (LCWE). LCWE-induced coronary inflammation gradually progressed in a time-dependent manner and expanded to all layers of the vessel wall over 28 days. In addition, frequent elastin degradation was observed and abundant α-smooth muscle actin (SMA)-positive vascular smooth muscle cells (VSMCs) infiltrated into the intima. Furthermore, most VSMCs were positive for proliferating cell nuclear antigen (PCNA) following staining, suggesting that VSMCs likely exhibited a proliferative phenotype. In conclusion, we show a novel mouse model of coronary stenosis induced by LCWE that is characterized by coronary stenosis with severe coronary vasculitis and elastin degradation. In addition, VSMC proliferation plays an important role in the formation of coronary stenosis. This model is an appropriate model of KD coronary stenosis.
Identifiants
pubmed: 31932543
doi: 10.1538/expanim.19-0124
pmc: PMC7220718
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-241Références
Cardiovasc Hematol Agents Med Chem. 2008 Jan;6(1):44-52
pubmed: 18220720
Arthritis Rheum. 1985 Jun;28(6):652-9
pubmed: 3924060
BMC Immunol. 2012 Oct 17;13:56
pubmed: 23074996
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1423-33
pubmed: 25838430
Immunobiology. 2013 Feb;218(2):201-12
pubmed: 22633994
Circulation. 1996 Sep 15;94(6):1379-85
pubmed: 8822996
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1093-9
pubmed: 21330608
J Pediatr. 2006 Sep;149(3):426; author reply 426
pubmed: 16939768
Mod Rheumatol. 2020 Mar;30(2):350-357
pubmed: 30924376
Circ Res. 2016 Feb 19;118(4):692-702
pubmed: 26892967
Arerugi. 1967 Mar;16(3):178-222
pubmed: 6062087
Pediatr Res. 2017 Apr;81(4):593-600
pubmed: 27997528
Microbiol Immunol. 1979;23(9):825-31
pubmed: 395420
Circulation. 2005 Nov 8;112(19):2966-73
pubmed: 16275884
J Pediatr. 1993 Oct;123(4):657-9
pubmed: 8410524
Circulation. 2012 Mar 27;125(12):1542-50
pubmed: 22361326
Lancet. 2012 Apr 28;379(9826):1613-20
pubmed: 22405251
Lancet. 2019 Mar 16;393(10176):1128-1137
pubmed: 30853151
PLoS One. 2012;7(6):e38998
pubmed: 22723916
Int J Rheum Dis. 2018 Jan;21(1):31-35
pubmed: 29105353
Circ J. 2017 Dec 25;82(1):239-246
pubmed: 28855435
J Am Soc Nephrol. 2007 Aug;18(8):2311-9
pubmed: 17634441
Mod Rheumatol. 2014 Jan;24(1):120-8
pubmed: 24261768
Acta Histochem Cytochem. 2016 Feb 27;49(1):29-36
pubmed: 27006519
Inflamm Res. 2004 Feb;53(2):72-7
pubmed: 15021972
Nature. 1998 May 21;393(6682):276-80
pubmed: 9607766
Pediatr Int. 2019 Apr;61(4):397-403
pubmed: 30786118
Mod Rheumatol. 2010 Apr;20(2):160-7
pubmed: 19943075
Circulation. 2004 Oct 5;110(14):1953-9
pubmed: 15451791